Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Greenlane Holdings

Aurora Cannabis

Canopy Growth

Cronos Group

As the cannabis industry continues its growth in 2024, a confluence of regulatory, demographic, and market trends is shaping the sector. This has presented a fertile ground for savvy investors. Here's a deeper look into the evolving landscape of cannabis investments. This year could mark a significant turning point with the potential rescheduling of cannabis at the federal level. If cannabis can one day be federally legal it would be the biggest win for the industry.

This Is How Marijuana Stocks Will Be Impacted By Reform In 2024

Brookfield Renewable Partners

Canadian Natural Resources

Enbridge

Enterprise Products Partners

IonQ

JPMorgan Equity Premium Income ETF

Lithium Americas Corp

Defiance Nasdaq 100 Enhanced Options Income ETF

QuantumScape

Solventum Corporation

VictoryShares Free Cash Flow ETF

The "Undercovered" Dozen highlights twelve ideas from the previous month on stocks with limited coverage. QuantumScape, IonQ, Enbridge preferred shares, Tilray, and more are included this month.

The 'Undercovered' Dozen From April 2024

Village Farms International

What will happen to marijuana stocks if cannabis does not get rescheduled? Some see this as a possibility and investors want to be prepared. With all the recent talks of cannabis being dropped from a scheduled 1 to a class 3 substance it has led to a rise in trading. The speculation of what's next to come is also feeding into momentum pouring into the sector.

Ready To Invest? Here Are 3 Top Marijuana Stocks For You

Cannabis stocks are back in the spotlight and moving higher on news that the U.S. government is moving to reclassify the recreational drug and ease federal restrictions imposed on it. The Biden administration has taken steps to reclassify cannabis, also known as marijuana, as a Schedule III substance.

The 3 Best Cannabis Stocks to Buy in May 2024

Tilray Brands (NASDAQ: TLRY) stock price has suffered a harsh reversal as I predicted on May 1st as cannabis shares surged. It has retreated to $1.98, down by over 20% from its highest level this month and 33% lower than its 2024 high.

Tilray Brands stock price analysis: TLRY is extremely risky, avoid

Curaleaf Holdings, Inc.

Jazz Pharmaceuticals

Leafly Holdings

Among the emerging industries that have captured the attention of investors is the cannabis sector. The cannabis industry has experienced remarkable growth, giving rise to a new breed of top cannabis stocks to buy for investments in May.

7 Cannabis Stocks to Buy for a Smoking-Hot 2024

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

Whispers and rumors of widespread cannabis legalization are growing louder. Although the last major surge in top cannabis stocks during the late 2010s significantly eclipses today's market and per-share pricing, top cannabis stocks are gradually ticking upward.

The 7 Top-Selling Cannabis Companies Ranked by Revenue: Which Weed Stocks to Buy?

Multiple cannabis stocks to buy should climb higher thanks to Washington's efforts to help the sector. So far, the federal government looks poised to undertake two initiatives that should greatly boost marijuana companies in the long term.

Cashing In on Cannabis: 3 Stocks Primed to Surge on Federal Reforms

AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure Cannabis ETF 

The proposed rescheduling of cannabis is the biggest step forward for the industry in decades.

Cannabis Continues Powering To Big Gains With Historic DEA Rescheduling

BEND, Ore., May 03, 2024 (GLOBE NEWSWIRE) -- 10 Barrel Brewing Co. ("10 Barrel Brewing Co." or "10 Barrel"), a Pacific Northwestern pioneer in craft brewing, a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), unveils its latest creation: Pub Cerveza. Building upon the legacy of the ‘Cheap Fun.

10 Barrel Brewing Introduces Pub Cerveza: a New Twist on ‘Cheap Fun.' Series

Cannabis stocks reignited Tuesday afternoon after the U.S. Department of Justice announced that it would move to reclassify marijuana as a less dangerous drug. As a result of the breaking news, several leading cannabis stocks, like Tilray NASDAQ: TLRY, Aurora Cannabis NASDAQ: ACB, and Canopy Growth NASDAQ: CGC experienced notable upticks in volume and price, posting impressive double-digit intraday gains before pulling back on Wednesday.

Cannabis Stocks: Game-Changing Catalyst for the Sector?

TORONTO, May 02, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced a bold new range of cannabis-infused beverages from XMG , under two of its sub-brands: XMG Zero and XMG Plus (“XMG+”). XMG Zero, an extension of XMG's original core line, now offers two new THC beverages: Cream Soda Zero and Orange Soda Zero.

Tilray Brands Launches XMG Zero, a New ‘Better for You' Cannabis Beverage

The DEA recommended loosening regulations on marijuana yesterday. As a Schedule III drug, marijuana would still be regulated and some costs would rise for cannabis companies -- but others would fall.

Why Canopy Growth, Tilray, and Cronos Group Stocks Just Cratered

Bit Digital, Inc

Palantir Technologies

Many of yesterday's meme stocks to buy, once the darlings of speculative traders, now languish as forgotten relics at the bottom of portfolios, their potential for massive gains long since diminished. This popular sentiment — “It's only a loss if you sell” — might not hold much comfort anymore.

3 Meme Stocks to Buy on the Dip: April 2024

Cannabis stocks are falling on Wednesday as shares of marijuana companies are giving up some of the massive gains they saw yesterday. That rally came about after reports claimed the Biden Administration is moving forward with plans to reschedule cannabis from a Schedule I drug to a Schedule III drug.

Cannabis Stocks CGC, ACB, TLRY Drop After Huge Rescheduling Rally

Canopy Growth Corp. and Tilray Brands Inc. stocks made more modest moves on Wednesday after a huge rally in the previous session on plans by the Biden administration to reclassify pot as less dangerous under federal law.

Cannabis stocks settle down after rally on plans to reclassify pot as less dangerous

GrowGeneration Corp

OrganiGram Holdings Inc.

Constellation Brands

Though there has never been a shortage of enthusiasm and interest in cannabis stocks, many of them have failed to take off, with some even dropping more than 90% from their initial public offering (IPO) price and turning into penny stocks.

The next pot of gold? Marijuana stocks surge higher on promise of reclassification

The new Hefe Variety Pack is a Widmer brand expansion, including the brewery's flagship Hefe along with Imperial Hefe, Widberry Hefe, and Apricot Hefe.

Widmer Brothers Brewing Launches New Hefe Variety Pack With Revamped Versions of the Original American Hefeweizen

SNDL Inc.

Cannabis stocks have gone parabolic. Tilray Brands (TLRY) stock jumped by over 39% on Tuesday while Canopy Growth (CGC) soared by over 78%.

Here's the risk for buying TLRY, CGC, MSOS, and SNDL stocks

Warren Buffett is a well-known proponent of value investing. The legendary investor waits for the right valuation before making a big plunge.

Stock Market Crash Alert: 3 Must-Buy Cannabis Stocks When Prices Plunge

BigBear.ai Holdings

Clear Channel Outdoor Holdings

Nikola

Oatly

Purple Innovation

Virgin Galactic

Given the recent market volatility, many traders are trying to make money in penny stocks. With low prices and elevated volatility, penny stocks could be a great way for traders to cash in on breaking news and rapid changes in market sentiment.

Stock Market Crash Warning: Don't Get Caught Holding These 7 Penny Stocks

Tilray Brands and Bitcoin are fairly risky investments. Tilray's ambitions are large, but obstacles are proving to be persistent.

Tilray Brands Stock vs. Bitcoin: Which Investment Is Worth the Risk?

WASHINGTON — The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, the Associated Press has learned, a historic shift to generations of American drug policy that could have wide ripple effects across the country.

U.S. poised to ease restrictions on marijuana in historic shift, though it'll remain controlled substance

The US is planning to reclassify cannabis as a less dangerous drug in an historic shift that could have a significant impact across the country.

US plans to reclassify cannabis as less dangerous drug

American Homes 4 Rent

Cannabis company stocks skyrocketed Tuesday following multiple reports marijuana will be reclassified to a less dangerous drug schedule, which could broaden the substance's medical usage and cut down regulations tied to it.

Cannabis Stocks Spike Following Reports Marijuana Will Be Reclassified As Less Dangerous Drug

News for Tilray Brands Stock (TLRY)